Predictive risk markers in alcoholism

Area of Science:

• Medical research
• Clinical chemistry
• Public health

Background:

• Alcohol use disorders (AUD) are a major global health concern.
• Early detection and risk assessment for AUD are critical for effective treatment.
• Existing methods for detecting heavy drinking and associated risks require improvement.

Purpose of the Study:

• To review novel biomarkers and predictive algorithms for assessing alcohol use disorders (AUD).
• To highlight the importance of early detection and risk stratification in managing AUD.
• To discuss the role of biomarkers in predicting treatment response and disease progression.

Main Methods:

• Review of recent advances in clinical chemistry for detecting ethanol metabolites (PEth, EtG).
• Discussion of carbohydrate-deficient transferrin (CDT) as an indicator of severe alcohol problems.
• Exploration of predictive biomarkers and algorithms for assessing hepatic and extrahepatic morbidity.

Main Results:

• Novel assays (PEth, EtG) enable specific detection of heavy drinking.
• CDT measurements can indicate severe alcohol-related issues.
• Combined biomarkers and clinical data improve prediction of AUD progression and treatment response.

Conclusions:

• Biomarkers like PEth, EtG, and CDT offer improved detection of AUD.
• Predictive algorithms integrating biomarkers and clinical data can aid in early diagnosis and risk stratification.
• These advancements hold significant potential for improving clinical decision-making in AUD management.